AC
ZBH icon

AlphaCore Capital’s Zimmer Biomet ZBH Stock Holding History

AlphaCore Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
17,551
+6,392
+57% +$560K 0.03% 368
2026
Q1 		$1.01M Buy
11,159
+2,344
+27% +$215K 0.02% 386
2025
Q4 		$793K Buy
+8,815
New +$836K 0.02% 475

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AlphaCore Capital's ZBH Position: Q2 2026 in Review

AlphaCore Capital increased its Zimmer Biomet (ZBH) stake by 57% in Q2 2026, buying an estimated $560K and bringing the position to 17,551 shares worth $1.51M. The position accounts for 0.03% of the portfolio, ranked #368.

AlphaCore Capital first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • AlphaCore Capital held 17,551 shares of Zimmer Biomet worth $1.51M as of Q2 2026.
  • AlphaCore Capital bought 6,392 Zimmer Biomet shares in Q2 2026, an estimated $560K.
  • Zimmer Biomet made up 0.03% of AlphaCore Capital's portfolio in Q2 2026, its #368 holding.
  • AlphaCore Capital first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.